Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06343064
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-03-21
Brief Title:
Vebreltinib Plus PLB1004 in EGFR-mutated Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI
Sponsor:
Avistone Biotechnology Co Ltd
Organization:
Avistone Biotechnology Co Ltd
Organization Data
Organization:
Avistone Biotechnology Co Ltd
Class:
INDUSTRY
Study ID:
PLB1001PLB1004-NSCLC-IbII-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Avistone Biotechnology Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None